For the Inventor, By the Inventor

Enter inventor name

Le Mans, France

Jean-Pierre Robin

USPTO Granted Patents = 17

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 45(Granted Patents)

Location History:

Trange, FR (2003)
Charlottesville, VA (US) (2006 - 2007)
Le Mans, FR (1989 - 2008)
Nyon, CH (2010)

Company Filing History:

Societe D'etude Et De Recherche En Ingenierie Pharmaceutique Seripharm

Stragen Pharma Sa

Pierre Fabre Medicament

Oncopharm Corporation

Chemgenex Pharmaceuticals, Inc.

Universite Du Maine (le Mans)

Years Active: 1989-2010

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7842687 - Cephalotaxane derivatives and their processes of preparation and purification (2010-11-30),

2. 7432383 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor (2008-10-07),

3. 7285546 - Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents (2007-10-23),

4. 7279586 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor (2007-10-09),

5. 7220871 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor (2007-05-22),

6. 7169774 - Cephalotaxane derivatives and their processes of preparation and purification (2007-01-30),

7. 6987103 - Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents (2006-01-17),

8. 6831180 - Cephalotaxane derivatives and process for their preparation (2004-12-14),

9. 6825365 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor (2004-11-30),

10. 6613900 - Cephalotaxane derivatives and process for their preparation (2003-09-02),

11. 6579869 - Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents (2003-06-17),

12. 6265587 - Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor (2001-07-24),

13. 6180802 - Method for selective protection of baccatin derivatives and its application to taxane synthesis (2001-01-30),

14. 6107284 - Water-soluble derivatives of epipodophyllotoxin, process for their (2000-08-22),

15. 5643885 - Etoposide derivatives, process for preparing them, their use as a (1997-07-01),

Title: Innovations of Jean-Pierre Robin

Introduction

Jean-Pierre Robin is a notable inventor based in Le Mans, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of alkaloids used in chemotherapy. With a total of 17 patents to his name, his work has had a profound impact on medical research and treatment options.

Latest Patents

One of his latest patents is focused on cephalotaxane derivatives and their processes of preparation and purification. This invention presents a new general process for the asymmetric hemisynthesis of harringtonines and their analogs, which are crucial alkaloids utilized in chemotherapy. The process involves direct esterification of a natural cephalotaxine with an acylating compound, ensuring that the total content of impurities is lower than 1%. Another significant patent relates to intermediates for the hemisynthesis of taxanes and preparation processes thereof, which includes a precursor compound and derivatives for preparing a taxane and a baccatin derivative.

Career Highlights

Throughout his career, Jean-Pierre Robin has worked with several prominent companies in the pharmaceutical industry. Notable among these are Seripharm and Stragen Pharma. His expertise in the field has allowed him to contribute to various innovative projects that advance pharmaceutical research.

Collaborations

Jean-Pierre has collaborated with esteemed colleagues such as Robert Dhal and Luc Chanteloup. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Jean-Pierre Robin's contributions to the field of pharmaceuticals through his innovative patents and collaborations have significantly advanced medical research. His work continues to influence the development of effective chemotherapy treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…